Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04163809 · ClinicalTrials.gov registry record · NA

The Role of Virtual Reality During Regional Anesthesia

A NA study of Pain and Anxiety, sponsored by Cedars-Sinai Medical Center.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT04163809: Recruiting NA study of Pain and Anxiety, sponsored by Cedars-Sinai Medical Center.

NCT04163809 is a NA study of Pain and Anxiety that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 80 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04163809, a NA study of Pain and Anxiety, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

In this study, we will analyze the role of virtual reality in acute pain and anxiety management for regional anesthesia in pre-operative patients at Cedars-Sinai Medical Center.

Primary Outcome

questionnaire to rate anxiety on a scale of 0-10

Conditions Studied

Interventions

  • DEVICE Virtual Reality with Oculus Go headset

Study Locations (1)

California

  • Cedars Sinai Medical Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2020-01-27
Est. Completion 2026-06
Phase NA
Cedars-Sinai Medical Center

339 total trials

What NCT04163809 shows while recruiting

NCT04163809 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (74% lower).

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Virtual Reality with Oculus Go headset is the first listed.

NCT04163809 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04163809 about?

NCT04163809 is a clinical study titled "The Role of Virtual Reality During Regional Anesthesia". In this study, we will analyze the role of virtual reality in acute pain and anxiety management for regional anesthesia in pre-operative patients at Cedars-Sinai Medical Center.

What is the current status of trial NCT04163809?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2020-01-27. Estimated completion is 2026-06.

What conditions does trial NCT04163809 study?

This clinical trial studies the following conditions: Pain, Anxiety.

What interventions are being tested in trial NCT04163809?

The interventions under investigation include: Virtual Reality with Oculus Go headset (DEVICE).

Who is sponsoring clinical trial NCT04163809?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04163809 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04163809's enrollment target sits among peer trials

80 193rd of 374 higher than 171 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04163809, the US trial registry maintained by the National Library of Medicine. NCT04163809 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.